Evidence map›Paper›PMID 42258752›Full record

ArticleJCI insight2026

FOXC2 and WT1 regulate transcriptional reprogramming during the podocyte response to injury.

Sandrine Ettou, Anya Greenberg, Sangyoon Lee, Arjun Rajesh, Liang Sun, Nahid Tabibzadeh, Haruka Oishi, Ran Konoe, Phillip J McCown, Sean Eddy and 18 more

Abstract read
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Sandrine EttouDepartment of Urology, Boston Children's Hospital, Boston, Massachusetts, USA.
Anya GreenbergDivision of Nephrology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Sangyoon LeeDivision of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Arjun RajeshDivision of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Liang SunResearch Informatics, Department of Information Technology, Boston Children's Hospital, Boston, Massachusetts, USA.
Nahid TabibzadehNephrology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Haruka OishiNephrology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ran KonoeNephrology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Phillip J McCownDepartment of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
Sean EddyDepartment of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
Victoria DriscollDivision of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Tomoya MiyoshiJohn A. Paulson School of Engineering and Applied Sciences, Harvard University, Cambridge, Massachusetts, USA.
Ken HiratsukaNephrology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Jason LamDivision of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
R Sathish SrinivasanCardiovascular Biology Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Youngsook L JungDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts, USA.
Biju IsaacResearch Informatics, Department of Information Technology, Boston Children's Hospital, Boston, Massachusetts, USA.
Mingwei SunResearch Informatics, Department of Information Technology, Boston Children's Hospital, Boston, Massachusetts, USA.
Mary E TaglientiDepartment of Urology, Boston Children's Hospital, Boston, Massachusetts, USA.
Keith KellerDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Hong ChenDepartment of Surgery, Harvard Medical School, Boston, Massachusetts, USA.
Matthias KretzlerDepartment of Internal Medicine, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, USA.
Astrid WeinsDepartment of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Ryuji MorizaneNephrology Division, Massachusetts General Hospital, Boston, Massachusetts, USA.
Shira RockowitzResearch Informatics, Department of Information Technology, Boston Children's Hospital, Boston, Massachusetts, USA.
Valerie A SchumacherDepartment of Urology, Boston Children's Hospital, Boston, Massachusetts, USA.
Dongwon LeeDivision of Nephrology, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
Jordan A KreidbergDepartment of Urology, Boston Children's Hospital, Boston, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcriptional reprogramming has an important role in kidney glomerular disease. Using in vivo murine models of podocyte injury, we studied the roles of the FOXC2 and WT1 transcription factors (TFs) in podocyte injury. Podocytes are a crucial cell type of glomeruli, the filtration units of each nephron. Podocyte injury is often the incipient event leading to chronic kidney disease. It is well established that the TFs FOXC2 and WT1 are required in podocytes to maintain the glomerular filtration barrier. Their role in the response to injury is less well understood. Here, we tested the hypothesis that FOXC2 and WT1 act together to mediate transcriptional reprogramming in response to podocyte injury. Similarly to that of WT1, genome-wide FOXC2 binding to target genes is dynamic during the course of injury, initially increasing, but late in injury there is a dramatic decrease in FOXC2 expression and in its binding to target genes. Podocyte-specific inactivation of FoxC2 or Wt1 in adult mice limits the transcriptional response to injury. Correlating FOXC2 and WT1 ChIP-seq analyses demonstrated that they co-bind many genes expressed in podocytes. Thus, reprogramming the transcriptome involves dynamic changes in the binding of FOXC2 and WT1 to their target genes during a reparative injury response.

Indexed as

Cellular ReprogrammingForkhead Transcription FactorsPodocytesWT1 ProteinsAnimalsDisease Models, AnimalKidney GlomerulusMiceTranscription, GeneticForkhead Transcription Factorsmesenchyme fork head 1 proteinWT1 protein, mouseWT1 ProteinsGeneticsMolecular biologyNephrologyTranscription

Identifiers

PMID42258752
PMCPMC13313500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.